Tobramycin: Difference between revisions
From IDWiki
(Redirected page to Aminoglycosides) Tag: New redirect |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | == Background == |
||
| ⚫ | |||
| + | |||
| + | * An [[Aminoglycosides|aminoglycoside]] |
||
| + | * Poor lung and CNS penetration |
||
| + | |||
| + | == Dosing == |
||
| + | |||
| + | * Refer to [[Aminoglycosides#Dosing|Aminoglycosides]] page |
||
| + | * Inhaled tobramycin: 160 mg nebulized q8h or 300 mg nebulized q12h |
||
| + | |||
| ⚫ | |||
Latest revision as of 16:51, 26 May 2021
Background
- An aminoglycoside
- Poor lung and CNS penetration
Dosing
- Refer to Aminoglycosides page
- Inhaled tobramycin: 160 mg nebulized q8h or 300 mg nebulized q12h
